Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation

OBJECTIVES: Compare the effect of apixaban and warfarin on coagulation and primary haemostasis biomarkers in atrial fibrillation (AF). METHODS: The biomarker substudy from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial included 4850 patients with AF...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Heart
Главные авторы: Christersson, Christina, Wallentin, Lars, Andersson, Ulrika, Alexander, John H, Alings, Marco, De Caterina, Raffaele, Gersh, Bernard J, Granger, Christopher B, Halvorsen, Sigrun, Hanna, Michael, Huber, Kurt, Hylek, Elaine M, Lopes, Renato D, Oh, Byung-Hee, Siegbahn, Agneta
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2019
Предметы:
Arrhythmias and Sudden Death
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6388910/
https://ncbi.nlm.nih.gov/pubmed/30209126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2018-313351
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы